The latest market research forecasts that the global luciferase assays market is on a rapid growth trajectory, expected to reach a valuation of US$ 3 billion by the year 2032. This marks a significant increase from an estimated US$ 1.3 billion at the end of 2022, charting a strong compound annual growth rate (CAGR) of 7.8% over the forecast period of 2022 to 2032.
Luciferase assays, known for their pivotal role in molecular biology and genetic engineering, have become a cornerstone in the study of gene expression, replacing older technologies such as the chloramphenicol acetyltransferase gene as a reporter. This advancement is a key driver behind the burgeoning demand and subsequent market growth of luciferase assays globally. Their application spans gene expression studies and monitoring gene transcription or translation levels, underpinning the market’s expansion.
Get a PDF Sample with Latest Market Insights: https://www.futuremarketinsights.com/reports/sample/rep-gb-5565
The reduction in production costs coupled with an increase in per capita income are contributing factors to the optimistic market outlook. Additionally, the rising demand for regular medications, including hydroxychloroquine, has indirectly fostered growth opportunities for the luciferase assays market.
Further bolstering the market’s growth is the widespread application of luciferase assays in detecting and evaluating ATP, alongside technological advancements facilitating camera-aided quantitative imaging of gene expression. The food and beverage sector also leverages luciferase assays for microbiological contamination checks, further expanding the market’s reach.
A pivotal development in the luciferase assays market is the advent of advanced technologies that allow for the quantitative visualization of gene expression at the single-cell level. This is achieved through real-time imaging of luminescence using highly sensitive charged-coupled device (CCD) cameras, marking a significant leap forward in the field.
As the pharmaceutical and biotechnology industries continue to evolve, the demand for upgraded vaccines and treatment medications is expected to rise. This, in turn, is projected to fuel the demand for luciferase assays, reinforcing the market’s growth trajectory through the forecast period and beyond.
The luciferase assays market is at the cusp of a transformative phase, driven by relentless innovation and an expanding array of applications across industries. As it moves towards a promising future, stakeholders in the pharmaceutical, biotechnology, and food and beverage sectors are poised to witness significant benefits from the advancements in luciferase assay technologies.
Methodology Details Just a Click Away: https://www.futuremarketinsights.com/request-report-methodology/rep-gb-5565
Key Takeaways:
- Advances in the pharmaceutical and biotechnology industry will boost the market prospects for luciferase assays.
- North America’s luciferase assays market will dominate the global marketplace with a share of 37.3%.
- Asia Pacific will offer several lucrative opportunities to the luciferase assays market during the forecast period.
- The start-ups in this market are focusing on R&D activities and product innovation.
Competitive Landscape:
Life Technologies, Sigma Aldrich, Thermo Fisher, Promega, Clontech, Invivogen, Roche Applied Sciences, Switchgear Genomics, Origene, Perkin Elmer, EMD Millipore, Clontech, Gold Biotechnology, Lonza and GE Healthcare Life Sciences among others are some of the major players in the luciferase assays market profiled in the full version of the report.
Leading market players are focusing on new product launches to cater to the growing demand for the target product. These businesses employ collaboration and acquisition strategies to strengthen their market position.
Key Segments:
By Assay Type:
- Beta-galactosidase assays
- Luciferase assays
- Fluorescent protein related assays
- Chloramphenicol acetyltransferase assays
- Others
By Application:
- Gene expression
- Post-translational modification
- Protein-protein interaction
- Metabolic activity
- Others
By Region:
- North America
- Latin America
- Asia Pacific
- MEA
- Europe
Request Purchase on Report: https://www.futuremarketinsights.com/checkout/5565
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
